Impact of galcanezumab on total pain burden: findings from phase 3 randomized, double-blind, placebo-controlled studies in patients with episodic or chronic migraine (EVOLVE-1, EVOLVE-2, and REGAIN trials)

Abstract Background Focus on the frequency of migraine pain may undervalue the total burden of migraine as pain duration and severity may present unique, additive burden. A composite measure of total pain burden (TPB; frequency, severity, and duration) may provide a more comprehensive characterizati...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Jessica Ailani, J. Scott Andrews, Mallikarjuna Rettiganti, Robert A. Nicholson
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMC 2020-10-01
Seri Bilgileri:The Journal of Headache and Pain
Konular:
Migraine
Chronic migraine
Burden of illness
Galcanezumab
Headache
Pain
Online Erişim:http://link.springer.com/article/10.1186/s10194-020-01190-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller